Back to search

University of Southampton

Mediators of airway remodelling in asthma

Abstract

dc:description.abstract

<p><span >The asthmatic airway demonstrates structural changes termed airway remodelling which include subepithelial collagen deposition and an increase in numbers of myofibroblasts in the mucosa. These changes may contribute to bronchial hyperresponsiveness and to decline in lung function in asthma.</span></p> <p><span >The hypothesis was proposed that proteases, and in particular the plasminogen activating system, may mediate airway remodelling through the release of growth factors such as basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-β) from their binding to the extracellular matrix. The ability of bronchoalveolar lavage fluid (BALF) from asthmatic and non asthmatic subjects to stimulate proliferation <i>in vitro </i>of a transformed human fetal lung fibroblast cell line, MRC-5, was studied by measuring <sup>3</sup>H-thymidine uptake.</span></p> <p><span >Use of blocking antibodies and antiproteases demonstrated significant inhibition of BALF-induced fibroblast DNA synthesis (BIDS) by anti-bFGF, by a protease inhibitor cocktail and by the specific plasmin inhibitor, α2-antiplasmin. Plasmin concentrations of BALF correlated with BIDS. Plasmin was shown to stimulate marked proliferation of fibroblasts, an effect that was profoundly inhibited by anti-bFGF. Measurement of cell supernatant concentrations demonstrated rapid release of bFGF from fibroblasts exposed to plasmin. Immunofluorescent confocal microscopy demonstrated plasmin-induced loss of bFGF staining from fibroblasts <i>in vitro. </i>These observations suggest that plasmin is an important fibroproliferative agent in BALF mediating its activity through autocrine release of bFGF.</span></p> <p><span >BIDS within an asthmatic group correlated significantly with bronchial hyperresponsiveness and BALF from steroid-naïve asthmatic subjects with marked bronchial hyperresponsiveness stimulated significantly greater BIDS than that from non-asthmatic subjects. BIDS also correlated with plasmin, bFGF and TGF-β levels in the BALF. Six weeks treatment with inhaled budesonide, nedocromil or placebo led to significant reductions in BIDS and plasmin concentrations only in the inhaled corticosteroid group and bFGF concentrations fell following treatment with budesonide, a change that was significantly different from that due to placebo.</span></p>

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2003

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McConnell, William David

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

McConnell, William David. Mediators of airway remodelling in asthma. doctoral thesis, University of Southampton, 2003.